APOB and atherosclerosis: Thus, the accumulating evidence from research in animal models, observational investigations, and Mendelian randomization studies points to the effects of CETP on apoB, rather than effects on HDL-C (or LDL-C), as the predominant mechanism for reducing risk of ASCVD.